Astec LifeSciences Limited (ASTEC.BO)
INR 1080.05
(-0.64%)
INR 1080.05
(-0.64%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 4.58 Billion | 6.28 Billion | 6.76 Billion | 5.54 Billion | 5.22 Billion | 4.3 Billion |
| Cost of Revenue | 4.17 Billion | 4.05 Billion | 3.9 Billion | 3.45 Billion | 3.4 Billion | 2.81 Billion |
| Gross Profit | 409.03 Million | 2.22 Billion | 2.85 Billion | 2.09 Billion | 1.81 Billion | 1.49 Billion |
| Operating Expenses | 830.69 Million | 1.79 Billion | 1.65 Billion | 1.19 Billion | 1.07 Billion | 806.1 Million |
| Selling, General and Administrative Expenses | 97.64 Million | 197.66 Million | 189.75 Million | 129.01 Million | 129.36 Million | 83.65 Million |
| Research and Development Expenses | 27 Million | 14.85 Million | 9.14 Million | 9.22 Million | 8.91 Million | 8.71 Million |
| Other Expenses | 1.22 Billion | 1 Million | 3.27 Million | 47 Thousand | 2.41 Million | 1.19 Million |
| Cost and Expenses | 5 Billion | 5.84 Billion | 5.56 Billion | 4.65 Billion | 4.48 Billion | 3.62 Billion |
| Operating Income | -415.93 Million | 450.03 Million | 1.21 Billion | 870.09 Million | 633.31 Million | 594.46 Million |
| Interest Expense | 252.25 Million | 201.58 Million | 86.94 Million | 47.51 Million | 125.94 Million | 123.75 Million |
| Income Tax Expense | -148.56 Million | 93.53 Million | 312.43 Million | 240.02 Million | 138.25 Million | 201.38 Million |
| Earnings before Tax | -617.47 Million | 349.47 Million | 1.21 Billion | 890.7 Million | 613.52 Million | 559.04 Million |
| Net Income | -469.29 Million | 255.64 Million | 898.58 Million | 650.48 Million | 475.11 Million | 357.36 Million |
| Earnings Per Share Basic | -23.93 | 13.04 | 45.87 | 33.23 | 24.29 | 18.28 |
| Earnings Per Share Diluted | -23.93 | 13.04 | 45.85 | 33.21 | 24.27 | 18.26 |
| Weighted Average Shares Outstanding | 19.6 Million | 19.6 Million | 19.58 Million | 19.57 Million | 19.56 Million | 19.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.61 Million | 19.6 Million | 19.59 Million | 19.58 Million | 19.57 Million | 19.57 Million |
| Gross Margin | 0.09 | 0.35 | 0.42 | 0.38 | 0.35 | 0.35 |
| EBIT Margin | -0.00 | 0.14 | 0.24 | 0.21 | 0.20 | 0.21 |
| Profit Margin | -0.10 | 0.04 | 0.13 | 0.12 | 0.09 | 0.08 |
| EBITDA | -2.68 Million | 893.14 Million | 1.64 Billion | 1.19 Billion | 971.11 Million | 876.29 Million |
| Earnings Before Tax Margin | -0.09 | 0.07 | 0.18 | 0.16 | 0.12 | 0.14 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 985.45 Million | 693.72 Million | 4.58 Billion | 1.53 Billion | 507.94 Million | 1.1 Billion |
| Cost of Revenue | 802.26 Million | 1.07 Billion | 4.17 Billion | 1.29 Billion | 353.18 Million | 760.25 Million |
| Gross Profit | 183.18 Million | -377.14 Million | 409.03 Million | 247.28 Million | 154.75 Million | 347.64 Million |
| Operating Expenses | 495.24 Million | 178.05 Million | 830.69 Million | 210.26 Million | 425.09 Million | 473.44 Million |
| Selling, General and Administrative Expenses | 231.21 Million | 178.05 Million | - | 210.26 Million | 193.75 Million | 209.41 Million |
| Research and Development Expenses | - | - | - | 27 Million | - | - |
| Other Expenses | 495.24 Million | 9.23 Million | 56.43 Million | 20.47 Million | 9.09 Million | 9.78 Million |
| Cost and Expenses | 1.29 Billion | 1.24 Billion | 5 Billion | 1.5 Billion | 778.28 Million | 1.23 Billion |
| Operating Income | -312.05 Million | -555.2 Million | -421.66 Million | 37.01 Million | -270.34 Million | -125.8 Million |
| Interest Expense | 93.34 Million | 70.42 Million | 252.25 Million | 66.74 Million | 60.94 Million | 59.93 Million |
| Income Tax Expense | 80 Thousand | -219.24 Million | -148.56 Million | 379 Thousand | -78.93 Million | -41.8 Million |
| Earnings before Tax | -385.4 Million | -616.39 Million | -617.47 Million | -9.26 Million | -322.19 Million | -175.95 Million |
| Net Income | -385.59 Million | -397.24 Million | -469.29 Million | -9.73 Million | -243.34 Million | -134.27 Million |
| Earnings Per Share Basic | -19.66 | -20.26 | - | -0.50 | -12.41 | -6.85 |
| Earnings Per Share Diluted | -19.66 | -20.26 | - | -0.50 | -12.41 | -6.85 |
| Weighted Average Shares Outstanding | 19.61 Million | 19.6 Million | 19.61 Million | 19.47 Million | 19.6 Million | 19.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.61 Million | 19.6 Million | 19.61 Million | 19.47 Million | 19.6 Million | 19.6 Million |
| Gross Margin | 0.19 | -0.54 | 0.09 | 0.16 | 0.30 | 0.31 |
| EBIT Margin | -0.18 | -0.67 | - | 0.08 | -0.34 | -0.02 |
| Profit Margin | -0.39 | -0.57 | -0.10 | -0.01 | -0.48 | -0.12 |
| EBITDA | -177.35 Million | -462.55 Million | - | 127.08 Million | -174.21 Million | -24.43 Million |
| Earnings Before Tax Margin | -0.32 | -0.80 | -0.09 | 0.02 | -0.53 | -0.11 |
SASKEN
PUUILO
300699
BETR
9594
WAY